home / stock / kne:cc / kne:cc news


KNE:CC News and Press, Kane Biotech Inc. From 04/07/22

Stock Information

Company Name: Kane Biotech Inc.
Stock Symbol: KNE:CC
Market: TSXVC
Website: kanebiotech.com

Menu

KNE:CC KNE:CC Quote KNE:CC Short KNE:CC News KNE:CC Articles KNE:CC Message Board
Get KNE:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

KNE:CC - STEM Animal Health Awarded Veterinary Oral Health Council (VOHC) Seal of Acceptance for Pet Oral Care Water Additive

WINNIPEG, Manitoba, April 07, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), is pleased to announce today that STEM Animal Health Inc. (“STEM”) has been awarded the prestigious Veterinary Oral ...

KNE:CC - IIROC Trading Halt - KNE

IIROC Trading Halt - KNE Canada NewsWire VANCOUVER, BC , April 7, 2022 /CNW/ - The following issues have been halted by IIROC: Company: Kane Biotech Inc. TSX-Venture Symbol: KNE All Issues: Yes Reason: At the Request of the Company Pending New...

KNE:CC - Kane Biotech Appoints Dr. Gregory Schultz as Chief Scientific Officer

WINNIPEG, Manitoba, April 05, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announced today the appointment of Gregory Schultz, PhD, a world renowned expert on biofilms, as Chief Scientific Officer (CSO). ...

KNE:CC - Kane Biotech Announces Fourth Quarter and Full Year 2021 Financial Results

WINNIPEG, Manitoba, March 24, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), today announced its fourth quarter and full year 2021 financial results. Fourth Quarter Financial Highlights Tota...

KNE:CC - Kane Biotech Successfully Completes Safety and Biocompatibility Studies for DispersinB® Wound Gel in Preparation for Human Clinical Trials

WINNIPEG, Manitoba, March 22, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech,” or “the Company”) announced positive results from biocompatibility and in vivo safety studies in preparation for human clinical trials set to begin ...

KNE:CC - Kane Biotech to Release Fourth Quarter and Full Year 2021 Financial Results on March 24 - Conference Call to Follow

WINNIPEG, Manitoba, March 17, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and ...

KNE:CC - Kane Biotech Announces Private Placement Offering

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, March 15, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced its intention to undertake a non...

Previous 10 Next 10